Braverman’s reappointment highlights double standards over national security says Penman

The FDA has highlighted the double standards of reappointing Suella Braverman as Home Secretary less than a week after being dismissed from the same post for a security breach.
Dave Penman, FDA General Secretary, told Rajeev Syal at the Guardian that “any civil servant who had knowingly shared confidential government information… would face gross misconduct charges and in all likelihood dismissal.” Penman continued that “this is not theoretical” as civil servants have lost their security clearance and been subsequently sacked for deliberately sharing confidential information, as Braverman has admitted doing. “There rightly should be no exceptions when it comes to national security”, argued Penman.
After Braverman made an appearance in the House of Commons to address her dismissal, Penman appeared on ITV News to demonstrate how the Home Secretary’s answers failed to assuage concerns regarding the six times she sent official government documents from her personal email. Speaking to Anushka Asthana, Penman stated that is was “extraordinary that a minister would be… routinely sharing information outside of government” and he insisted that we “can’t have one rule for ministers and one rule for civil servants”.
Related News
-
FDA rejects claims civil service to blame for delays to Northern Ireland infrastructure projects
The FDA’s National Officer for Northern Ireland Robert Murtagh has spoken out against claims that the Northern Ireland Civil Service, were to blame for the failure of infrastructure projects to be completed on time.
-
Penman joins panel discussion on ethical leadership in government at IfG ‘Nolan Principles at 30’ conference
FDA General Secretary Dave Penman took part in a panel discussion covering the question ‘How can politicians demonstrate ethical leadership?’.
-
Carers Week 2025 – launching our Carers’ Survey
To mark Carers Week 2025 (9-15 June), the FDA is launching a survey of carers in the civil service to find out what progress has been made since our 2021 report, and what still needs to be done.